Close Menu

NEW YORK (GenomeWeb) – Exact Sciences announced today plans for an underwritten public offering of $650 million worth of 0.3750 percent convertible senior notes due 2027. 

The company has also granted the underwriter a 30-day option to purchase up to an additional $97.5 million of the notes to cover any over-allotments. BofA Merrill Lynch is acting as sole book-running manager for the offering.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.